Treatment of Asthma with Bronchiectasis

Core Treatment Principles

The American Thoracic Society recommends that inhaled corticosteroids should be continued for asthma control in patients with coexisting bronchiectasis, as asthma represents a clear indication for their use despite the general recommendation against routine inhaled corticosteroids in bronchiectasis alone 1, 2, 3, 4
The British Thoracic Society suggests that the management requires addressing both conditions simultaneously, recognizing that asthma is an established indication for treatments otherwise not recommended in bronchiectasis alone 1, 2, 3, 4

The Global Initiative for Asthma recommends continuing inhaled corticosteroids as they have an established role in asthma management, even in the presence of bronchiectasis 1, 2, 3, 4
The American College of Chest Physicians suggests optimizing asthma control using standard asthma guidelines, ensuring allergies are also well-managed 5
The European Respiratory Society recommends using bronchodilators (short- or long-acting) as needed for breathlessness and before other inhaled therapies to optimize pulmonary deposition and tolerability 1, 2, 3, 4, 6

The British Thoracic Society suggests that all patients with chronic productive cough must be taught airway clearance techniques by a trained respiratory physiotherapist, performing 10-30 minute sessions once or twice daily 1, 2, 3, 4, 7
The American Thoracic Society recommends reviewing airway clearance technique within 3 months of initial assessment and annually thereafter, or whenever clinical deterioration occurs 1, 2, 3, 4
The European Respiratory Society suggests considering a trial of mucoactive treatment (such as carbocysteine for 6 months) in patients with difficulty expectorating sputum 1, 2, 3, 4, 7

The Infectious Diseases Society of America recommends treating all exacerbations with 14 days of antibiotics, selecting based on previous sputum culture results 5, 7
The American Thoracic Society suggests obtaining sputum for culture and sensitivity before starting antibiotics whenever possible 5, 7

The British Thoracic Society recommends assessing patients annually at minimum, with more frequent monitoring in severe disease 5, 8
The American College of Chest Physicians suggests performing pulse oximetry to screen for respiratory failure 5, 8
The European Respiratory Society recommends obtaining regular sputum cultures to monitor for pathogen emergence, particularly Pseudomonas aeruginosa (associated with three-fold increased mortality risk) 7

The American Thoracic Society warns against discontinuing inhaled corticosteroids simply because bronchiectasis is present—asthma remains a clear indication 1, 2, 3, 4
The Infectious Diseases Society of America advises against using shorter antibiotic courses for exacerbations; always use 14 days, particularly with Pseudomonas 5, 7
The European Respiratory Society cautions against extrapolating cystic fibrosis treatments to non-CF bronchiectasis, as treatment responses differ 7
The American College of Chest Physicians recommends always pre-treating with bronchodilators before nebulized therapies in asthma patients to prevent bronchoconstriction 1, 2, 3, 4